The AKT2 gene helps cells respond to insulin, move sugar from the blood into tissues, and support normal growth and energy use. When it does not work as expected, blood sugar control can change, and some people develop marked insulin resistance or diabetes, while a few variants that make the signal too strong can lead to low blood sugar and extra growth in some tissues. In medicine, this gene is important because it helps regulate a central pathway for metabolism.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are involved mainly in controlling when certain processes happen, where they happen, and how active they are. In combination, genes affect how your body develops and works, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
AKT2Gene function
What if the gene works
The AKT2 gene helps cells respond to insulin. It supports moving sugar from the blood into muscle and fat cells and helps regulate growth and energy use.
Risk
What if the gene does not work
Variants in the AKT2 gene can disrupt insulin signaling, leading to insulin resistance, high blood sugar, and sometimes early diabetes. Rarer activating variants can cause low blood sugar and overgrowth. Effects can range from mild to more severe.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by a pathogenic variant in the AKT2 gene in routine clinical guidelines. The AKT2 gene and the broader AKT pathway are being studied as possible drug targets and biomarkers, especially in cancer research, but this has not yet led to standard AKT2-specific care.
Conditions associated with AKT2
Gene function
What if the gene works
The AKT2 gene helps your body respond to insulin and manage blood sugar. It is a key part of how cells in muscle, fat, and liver take in glucose and decide whether to use it or store it. This is central to AKT2 gene function in insulin signaling and everyday energy balance.
AKT2 helps cells respond to insulin so glucose can move from the bloodstream into the cell. This is especially important in muscle and fat, where cells need a steady fuel supply.
In the liver, muscle, and fat, AKT2 helps cells decide when to store energy after a meal. It supports making glycogen, a stored form of sugar, and helps coordinate normal fat storage.
AKT2 passes along signals that tell cells when nutrients are available and growth is appropriate. It also supports routine cell survival pathways, helping tissues stay stable during everyday demands.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the AKT2 gene can alter the AKT2 protein’s shape, stability, or signaling strength inside cells. How variants in the AKT2 gene affect insulin signaling helps explain why some reduce activity and weaken the cell response to insulin, while rarer activating variants keep this signal more active than it should be. Milder loss-of-function variants may leave partial activity, while more severe variants can markedly disrupt signaling. This range can influence how early and how strongly metabolic features appear.
How variants are linked to conditions
Variants in the AKT2 gene are linked to rare conditions that affect blood sugar control and body growth. Pathogenic AKT2 gene changes can cause severe insulin resistance and diabetes, while other AKT2 variants have been associated with low blood sugar and one sided overgrowth. These are uncommon, well-established AKT2 gene variants linked to diabetes and hypoglycemia, not findings that apply to most people.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a particular gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to AKT2. In most cases, the main driver is the specific AKT2 gene change itself, while a person’s overall health can still affect how symptoms show up and how closely they need to be monitored.
Inheritance of AKT2 variants
AKT2-related conditions are usually inherited in an autosomal dominant pattern, which is how AKT2 gene variants are inherited in families when one changed copy is enough to affect health. If a parent carries a disease-causing variant in the AKT2 gene, each child has a 50% chance of inheriting it. Some people have a new, de novo variant in the AKT2 gene, meaning it arose for the first time in them rather than being passed down from either parent.
What does my AKT2 result mean for my family?
For known AKT2-related conditions, one changed copy of the gene can be enough to matter, so close relatives like parents, brothers, sisters, and children may also carry the same result. What it means for family members can differ a bit depending on the specific AKT2 change and the condition linked to it. Some AKT2 changes happen for the first time in one person, so the result did not always come from a parent.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the AKT2 gene is done by analyzing DNA from a blood, saliva, or cheek swab sample. AKT2 genetic testing for rare inherited conditions usually uses sequencing to read the gene and may also check for missing or extra pieces. Results can identify a pathogenic variant, no relevant variant, or a result that remains uncertain.
When should I consider getting a genetic test?
Genetic testing for the AKT2 gene may be worth considering when someone has unusual blood sugar problems, such as the body not responding well to insulin, diabetes starting young, or repeated low blood sugar without a clear cause, especially if it runs in the family. It can help clarify whether AKT2 is involved.
A genetic result is only one part of your health story
Genetic test results can provide useful information, but how much they reveal varies by the condition and the type of variant involved. Over time, the way the body works is also shaped by factors such as age, environment, lifestyle, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Small genetic differences can affect how your body handles certain medicines. These differences may change how quickly a drug is broken down, how strongly it works, or how sensitive you are to side effects. That helps explain why the same treatment works well for one person, works less well for another, or causes more unwanted effects in someone else. Genetic variation is common, and it is one of several factors that shape medication response alongside age, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences shape a person’s response to medications. It studies the connection between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the AKT2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or use. For concerns about side effects, a medicine not working as expected, or other treatment questions, talk with your doctor.
History
AKT2 entered genetics research in the early 1990s, when scientists identified it as one member of the human AKT gene family and linked it to earlier cancer biology work on the viral AKT oncogene. From these first observations, research expanded steadily. Studies later found extra copies of the AKT2 gene in some ovarian and pancreatic cancers, which helped establish it as part of a broader pathway involved in cell growth signals. In the 2000s, attention also turned to inherited AKT2 variants after reports connected rare changes in the gene with unusual patterns of blood sugar regulation and insulin resistance. Over time, the AKT2 gene became better known not through public headlines, but through its steady importance in cancer and metabolism research.